Phreesia, Inc. (NYSE:PHR) Receives $31.00 Consensus Price Target from Brokerages

Shares of Phreesia, Inc. (NYSE:PHR) have received an average rating of “Moderate Buy” from the eighteen ratings firms that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, sixteen have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $31.00.

PHR has been the topic of several analyst reports. Truist Financial set a $29.00 target price on Phreesia in a research report on Wednesday, December 10th. Weiss Ratings reissued a “sell (e+)” rating on shares of Phreesia in a report on Friday, October 31st. Mizuho lowered their price objective on shares of Phreesia from $36.00 to $28.00 and set an “outperform” rating on the stock in a research report on Wednesday, December 10th. Zacks Research raised shares of Phreesia from a “hold” rating to a “strong-buy” rating in a research report on Monday, December 8th. Finally, JMP Securities boosted their target price on shares of Phreesia from $30.00 to $34.00 and gave the company a “market outperform” rating in a research note on Monday, September 8th.

Phreesia Stock Performance

Shares of PHR stock opened at $17.13 on Thursday. The company has a quick ratio of 2.44, a current ratio of 2.44 and a debt-to-equity ratio of 0.01. Phreesia has a 52 week low of $15.41 and a 52 week high of $32.76. The firm has a market capitalization of $1.03 billion, a price-to-earnings ratio of -171.25 and a beta of 0.61. The stock has a fifty day moving average of $19.42 and a 200 day moving average of $23.97.

Phreesia (NYSE:PHR) last announced its earnings results on Monday, December 8th. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.11. Phreesia had a negative net margin of 1.16% and a negative return on equity of 1.31%. The firm had revenue of $120.33 million for the quarter, compared to analysts’ expectations of $119.98 million. During the same quarter in the previous year, the business posted ($0.25) EPS. The company’s quarterly revenue was up 12.7% on a year-over-year basis. As a group, research analysts expect that Phreesia will post -1.1 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Evan Roberts sold 1,888 shares of Phreesia stock in a transaction on Friday, October 17th. The stock was sold at an average price of $22.36, for a total transaction of $42,215.68. Following the transaction, the insider directly owned 724,949 shares in the company, valued at approximately $16,209,859.64. The trade was a 0.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, General Counsel Allison C. Hoffman sold 1,241 shares of the business’s stock in a transaction that occurred on Friday, October 17th. The shares were sold at an average price of $22.36, for a total value of $27,748.76. Following the transaction, the general counsel owned 135,737 shares of the company’s stock, valued at approximately $3,035,079.32. This trade represents a 0.91% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 7,534 shares of company stock valued at $165,514. 5.50% of the stock is owned by insiders.

Institutional Investors Weigh In On Phreesia

A number of institutional investors have recently bought and sold shares of PHR. Cubist Systematic Strategies LLC bought a new position in Phreesia during the first quarter valued at $774,000. Squarepoint Ops LLC lifted its holdings in shares of Phreesia by 243.6% in the 2nd quarter. Squarepoint Ops LLC now owns 100,922 shares of the company’s stock valued at $2,872,000 after acquiring an additional 71,553 shares during the last quarter. Farther Finance Advisors LLC grew its position in Phreesia by 9,375.0% in the second quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock worth $86,000 after acquiring an additional 3,000 shares in the last quarter. Arcadia Investment Management Corp MI increased its stake in Phreesia by 22.3% during the second quarter. Arcadia Investment Management Corp MI now owns 113,470 shares of the company’s stock worth $3,229,000 after acquiring an additional 20,700 shares during the last quarter. Finally, Acadian Asset Management LLC raised its position in Phreesia by 61.6% during the second quarter. Acadian Asset Management LLC now owns 364,194 shares of the company’s stock valued at $10,357,000 after purchasing an additional 138,877 shares during the period. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.